We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Dried Urine Spots Detect Cytomegalovirus in Newborns

By LabMedica International staff writers
Posted on 21 Jun 2012
Print article
Dried urine spots (DUS) can be used to provide a simple screening tool for congenital Cytomegalovirus (CMV) infection in newborn infants.

A standardized method for CMV quantification from DUS has been developed that uses molecular technology to detect and quantify the viral load in urinary samples.

Scientists at Johns Hopkins Medical Institutions (Baltimore, MD, USA) collected and tested archived urine samples from 27 congenitally infected and 15 uninfected neonates. DNA was extracted using an automated method from urine samples placed on filter paper discs. A quantitative CMV real-time polymerase chain reaction (rt-PCR) assay was performed on the extracted DNA, spiked urine samples, and suitable control samples.

Urine samples from congenitally infected newborns and negative controls either were diluted 1:10 or applied on filter paper at the same volume. The analytical sensitivity was determined of 100% of replicates at 7,500 CMV copies/mL. The actual detection limit was 22 DNA copies/disc. DNA copy number from DUS correlated well with copy number from 1:10 diluted urine, although there was a trend for lower levels from DUS. Amplification was performed on a 7500 Real-Time PCR System (Applied Biosystems; Foster City, CA, USA).

Concentrations of CMV DNA in the 27 positive samples ranged from 4.4 to 8.8 log10 copies/mL, with a mean of 6.5 log10 copies/mL. Three samples had CMV DNA levels that were greater than the highest concentration of the spikes urine tested for measurable range calculation. This screening method could be used to detect the presence of congenital CMV infection by inserting a filter paper in the newborn's diaper and therefore for this purpose, quantification may not be necessary.

The authors concluded that the assay may provide a simple and rapid tool for CMV detection and quantification from DUS in underdeveloped or developing countries in which diagnostic capabilities for CMV are lacking. Information on CMV prevalence from resource-constrained areas is currently limited due to lack of diagnostic infrastructure. The study was published on June 1, 2012, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
Johns Hopkins Medical Institutions
Applied Biosystems

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
New
Immunoassays and Calibrators
QMS Tacrolimus Immunoassays

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.